FORM 4 |
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility |
|
|
||
[ ] |
Check this box if no longer |
|
|
|||
|
||||||
(Print or Type Responses) |
1. Name and Address of Reporting Person*
|
2. Issuer Name and Ticker or Trading Symbol
|
6. Relationship of Reporting Person(s) to Issuer |
|||||||||||||
|
Director |
|
10% Owner |
||||||||||||
X |
Officer (give |
|
Other (specify |
||||||||||||
Senior Vice President, North American Sales and Marketing |
|||||||||||||||
(Last) (First) (Middle) c/o SangStat Medical Corporation |
3. I.R.S. Identification
|
4. Statement for 2/21/03 |
|
||||||||||||
(Street) Fremont CA 94555 |
5. If Amendment,
|
X |
Form filed by One Reporting Person |
||||||||||||
|
Form filed by More than One Reporting Person |
||||||||||||||
(City) (State) (Zip) |
Table I ¾ Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||||||
1. Title of Security |
2. Trans- |
2A. |
3. Trans- |
4. Securities Acquired (A) |
5. Amount of |
6. Owner- |
7. Nature of |
||||||||
Code |
V |
Amount |
(A) |
Price |
|||||||||||
Common Stock |
|
|
|
|
|
|
|
2,061 |
D |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
||||
* |
If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
|||
|
|
Persons who respond to the collection of information contained |
|
(Over) |
FORM 4 (continued) |
Table II ¾ Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||||||
1. Title of Derivative |
2. Conver- |
3. Trans- (Month/ |
3A. (Month/ |
4. Trans- |
5. Number of Deriv- |
6. Date Exer- |
7. Title and Amount of |
8. Price |
9. Number |
10. Owner- |
11. Nature |
||||
Code |
V |
(A) |
(D) |
Date |
Expira- |
Title |
Amount or |
||||||||
Option to purchase Common Stock |
$8.07 |
2/21/03 |
|
A |
|
40,000 |
|
(1) |
2/21/13 |
Common Stock |
40,000 |
|
40,000 |
D |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Explanation of Responses: |
|
|
|
/s/ Tamiko F. Lewis |
|
3/31/03 |
|
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. |
**Tamiko F. Lewis |
|
Date |
|
See18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
|
|
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, |
|
|
|
||
|
|
|
|
|
|
Potential persons who are to respond to the collection of information contained in this form are not |
|
|
|
||
|
|
|
|
||
|
|
|
Page 2 |